MYOPED silmatilgad, lahus Eesti - eesti - Ravimiamet

myoped silmatilgad, lahus

appasamy ocular devices (p) ltd - atropiin - silmatilgad, lahus - 0,1mg 1ml 5ml 1tk

MIO-CHOL süstelahus Eesti - eesti - Ravimiamet

mio-chol süstelahus

appasamy ocular devices (p) ltd - karbakool - süstelahus - 0,1mg 1ml 1ml 10tk

LASCA õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

lasca õhukese polümeerikattega tablett

exeltis baltics uab - dienogest+etünüülöstradiool - õhukese polümeerikattega tablett - 2mg+0,03mg 63tk; 2mg+0,03mg 126tk; 2mg+0,03mg 273tk

TRI-REGOL kaetud tablett Eesti - eesti - Ravimiamet

tri-regol kaetud tablett

gedeon richter plc. - levonorgestreel+etünüülöstradiool - kaetud tablett - 75mcg+40mcg/50mcg+30mcg/125mcg+30mcg 15tk / 18tk / 30tk

Comirnaty Euroopa Liit - eesti - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.

BELARA PLUS õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

belara plus õhukese polümeerikattega tablett

gedeon richter plc. - kloormadinoon+etünüülöstradiool - õhukese polümeerikattega tablett - 0+0/2mg+0,03mg 42tk / 126tk; 0+0/2mg+0,03mg 7tk / 21tk; 0+0/2mg+0,03mg 21tk / 63tk

CLEODETTE õhukese polümeerikattega tablett Eesti - eesti - Ravimiamet

cleodette õhukese polümeerikattega tablett

actavis group ptc ehf. - drospirenoon+etünüülöstradiool - õhukese polümeerikattega tablett - 3mg+0,03mg 273tk; 3mg+0,03mg 63tk; 3mg+0,03mg 126tk; 3mg+0,03mg 42tk

LENZETTO transdermaalne sprei, lahus Eesti - eesti - Ravimiamet

lenzetto transdermaalne sprei, lahus

gedeon richter plc. - östradiool - transdermaalne sprei, lahus - 1,53mg 1annus 168annus 1tk; 1,53mg 1annus 56annus 1tk